LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)

Filter results: >>>>
Cell Small Molecule GR_AOC
BT-20 Momelotinib 0.2982
BT-20 Dasatinib 0.8755
BT-20 Dovitinib 0.5738
BT-20 Enzastaurin -0.0904
BT-20 Erlotinib 0.1661
BT-20 Alvocidib 1.1891
BT-20 Foretinib 0.6967
BT-20 Pictilisib 0.6248
BT-20 GDC-0980 1.0410
BT-20 Gefitinib 0.0782
BT-20 Geldanamycin 1.0228
BT-20 GSK 690693 0.3945
BT-20 GSK1059615 0.8931
BT-20 GSK1904529A 0.0734
BT-20 Omipalisib 1.2231
BT-20 GW843682X 0.7556
BT-20 HG-5-113-01 0.4048
BT-20 HG-5-88-01 0.1624
BT-20 HG-6-64-01 0.3550
BT-20 Imatinib -0.0069
BT-20 JNK-9L 0.6159
BT-20 JW-7-24-1 0.2993
BT-20 KIN001-043 0.0871
BT-20 Lapatinib 0.0664
BT-20 LDN-193189 0.4508